I recently had the pleasure to spend time with the team at Applied Clinical Trials. Following our discussion they published an interview in the September edition of Applied Clinical Trials Magazine.
The interview is titled “Workforce Readiness Technology Minimizes Risk in Clinical Trials” and it explores how ArcheMedX is enabling Sponsors, CROs, and other trial stakeholders to improve clinical trial readiness.
Here’s the introduction and the full interview can be found below. Enjoy!
“Clinical trials often encounter operational challenges and sponsors and CROs seek effective site-readiness practices. In this interview, Joel B. Selzer, co-founder and CEO, ArcheMedX, Inc., discusses the impact that healthcare technology has on clinical trials, focusing on the development of the company’s workforce readiness platform.”
Related Post
The Compounding Power of Training: Early Investment Yields Exponential Returns
Why investing in truly effective training from the outset can pay off exponentially for clinical…
ArcheMedX Team
Raising the Bar: Why Quality and Training Will Define Your Success Under ICH E6(R3)
As clinical trials become increasingly complex, trial leaders are faced with a critical challenge: how…
ArcheMedX Team
Rethinking Training: The Benefits of Embracing ‘Desirable Difficulties’
Four strategies for implementing this approach in clinical trial staff and site training.Brian S. McGowan,…
